PPBT

Purple Biotech (PPBT)

Purple Biotech Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PPBT

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/05	05:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2024/06/03	19:21	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2024/06/01	21:00	GlobeNewswire Inc.	Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer	NASDAQ:PPBT	Purple Biotech Ltd
2024/05/21	20:40	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2024/05/21	20:30	GlobeNewswire Inc.	Purple Biotech Reports First Quarter 2024 Financial Results	NASDAQ:PPBT	Purple Biotech Ltd
2024/04/25	20:00	GlobeNewswire Inc.	Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting	NASDAQ:PPBT	Purple Biotech Ltd
2024/03/28	20:00	GlobeNewswire Inc.	Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024	NASDAQ:PPBT	Purple Biotech Ltd
2024/03/14	20:30	GlobeNewswire Inc.	Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology	NASDAQ:PPBT	Purple Biotech Ltd
2024/03/07	06:06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2024/03/06	06:00	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:PPBT	Purple Biotech Ltd
2024/03/05	21:58	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2024/03/05	21:55	GlobeNewswire Inc.	Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results	NASDAQ:PPBT	Purple Biotech Ltd
2024/02/27	21:10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2024/02/27	21:00	GlobeNewswire Inc.	Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024	NASDAQ:PPBT	Purple Biotech Ltd
2024/02/13	21:10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2024/02/13	21:00	GlobeNewswire Inc.	Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial	NASDAQ:PPBT	Purple Biotech Ltd
2024/02/01	21:40	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2024/02/01	21:40	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2024/02/01	21:30	GlobeNewswire Inc.	Purple Biotech Reaches Recommended Phase 2 Dose for NT219	NASDAQ:PPBT	Purple Biotech Ltd
2024/01/27	06:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2023/12/20	22:06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2023/12/20	22:05	GlobeNewswire Inc.	Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors	NASDAQ:PPBT	Purple Biotech Ltd
2023/12/14	21:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2023/12/14	20:50	GlobeNewswire Inc.	Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Trial	NASDAQ:PPBT	Purple Biotech Ltd
2023/11/21	21:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd
2023/11/21	20:50	GlobeNewswire Inc.	Purple Biotech Reports Third Quarter 2023 Financial Results	NASDAQ:PPBT	Purple Biotech Ltd
2023/11/15	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PPBT	Purple Biotech Ltd
2023/11/15	06:13	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PPBT	Purple Biotech Ltd
2023/11/14	06:11	Edgar (US Regulatory)	Form F-1/A - Registration statement for certain foreign private issuers: [Amend]	NASDAQ:PPBT	Purple Biotech Ltd
2023/11/02	20:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PPBT	Purple Biotech Ltd